Patent Number: 6,254,851

Title: Diagnostic agents for pancreatic exocrine function

Abstract: The present invention provides a .sup.13 C-labeled oligosaccharide or polysaccharide or a salt thereof excluding U-.sup.13 C-maltose, .sup.13 C-starch, 1-.sup.13 C-maltotetraose and 1-.sup.13 C-amylose; a derivative of the .sup.13 C-labeled oligosaccharide or polysaccharide or salt thereof; a .sup.13 C-labeled inclusion complex or a salt thereof, which comprises a cyclodextrin or a modified derivative thereof as a host molecule; a .sup.13 C- or .sup.14 C-labeled fluorescein ester compound or a salt thereof; and a diagnostic agents for pancreatic exocrine function comprising these compounds .sup.13 C- or .sup.14 C-labeled.

Inventors: Kohno; Tadashi (Kanagawa, JP), Hosoi; Isaburo (Saitama, JP), Ohshima; Junko (Kanagawa, JP), Shibata; Kunihiko (Chiba, JP), Ito; Asuka (Kanagawa, JP)

Assignee: Tokyo Gas Company Limited

International Classification: A61K 49/18 (20060101); A61K 49/06 (20060101); A61K 51/04 (20060101); A61K 51/12 (20060101); A61K 51/06 (20060101); A61K 51/02 (20060101); C08B 37/00 (20060101); A61K 051/00 (); A61M 036/14 ()

Expiration Date: 07/03/2018